Wegovy

Wegovy is a brand name for the prescription medication semaglutide, administered via injection and specifically approved for weight management in adults. It functions similarly to the hormone GLP-1, which is involved in regulating appetite and food intake, leading to a reduction in hunger and, subsequently, weight loss. By aiding in substantial and sustained weight loss, Wegovy contributes to mitigating obesity-related health risks such as heart disease, diabetes, and high blood pressure. Its approval and use signify a shift towards treating obesity as a chronic condition that can be managed with long-term medical interventions, alongside lifestyle changes in diet and exercise, highlighting its importance in the broader context of health and weight management strategies.